CGON vs PH · $4.74B cap vs P/E 28, rev $19.85B
CG Oncology, Inc. Common stock (CGON) versus Parker-Hannifin Corporation (PH) — a side-by-side from cached financials, not a winner call.
CG Oncology, Inc. Common stock (CGON) is a biotechnology company listed on US.
Parker-Hannifin Corporation (PH) is a specialty industrial machinery company listed on US.
CGON does not have a complete income-statement cache yet.
Latest reported PH revenue for 2025-06-30 was $19.85B. Net income was $3.53B. PH currently screens at market cap $91.89B and trailing P/E 27.7.
CGON currently screens at market cap $4.74B. PH currently screens at market cap $91.89B and trailing P/E 27.7.
Not investment advice. Open the CGON and PH stock pages for the full models.
Not investment advice.